semaglutide benefits and side effects & Mental Health Exploring semaglutide for obesity treatment:

In Phase I clinical trials, PGN-EDO51 showed good safety, tolerability, and efficacy, and Phase II trials are ongoing

If approved, the drug, called MariTide, could make Amgen the first new entrant into a market thats been dominated by Novo Nordisk, which makes Ozempic and Wegovy, and Eli Lilly, which makes Mounjaro and Zepbound

Florida Blue Medicare Part D cannot cover Wegovy for weight loss by federal statute this is a statutory exclusion affecting all Medicare plans

It reflects a deeper immune imbalance involving the IL-17 and IL-23 inflammatory pathways, gut microbiome dysbiosis, genetic predisposition (HLA-B27 and related alleles), and environmental triggers including trauma, infection, and metabolic dysfunction

Heres what I tell patients considering GLP-1 therapy: This is a commitment